Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry-Reference-Cited by-同舟云学术

Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry

Published:2016-06 Issue:6 Volume:129 Page:615-619
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Bott-Kitslaar Dalene M.,Saadiq Rayya A.,McBane Robert D.,Loprinzi Charles L.,Ashrani Aneel A.,Ransone Teresa R.,Wolfgram Alissa A.,Berentsen Michelle M.,Wysokinski Waldemar E.

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study;Heit;Blood,2011

2. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Kearon;Chest,2012

3. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thromboembolism;Prandoni;Blood,2002

4. Bleeding complications associated with anticoagulant therapy in patients with cancer;Trujillo-Santos;Thromb Res,2010

5. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study;Meyer;Arch Intern Med,2002

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Rivaroxaban Versus Enoxaparin in Prevention of Recurrence of Venous Thrombo-Embolism Events in Cancer Patients: A Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2024-01

2. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment;Thrombosis and Haemostasis;2022-12-27

3. Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry;Research and Practice in Thrombosis and Haemostasis;2022-10

4. Building a CAT clinic - real-world systems approaches to prevention and treatment;Thrombosis Research;2022-05

5. WITHDRAWN: Building a CAT clinic - real-world systems approaches to prevention and treatment;Thrombosis Research;2022-03